RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000077.xml
PDF herunterladen
Semin Thromb Hemost 2011; 37(3): 280-297
DOI: 10.1055/s-0031-1273092
© Thieme Medical PublishersDOI: 10.1055/s-0031-1273092
Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
31. März 2011 (online)
ABSTRACT
Obstructive sleep apnea syndrome (OSAS) is a chronic disease characterized by recurrent episodes of partial or complete upper airway collapse and obstruction during sleep, associated with intermittent oxygen desaturation, sleep fragmentation, and symptoms of disruptive snoring and daytime sleepiness. Increasing focus is being placed on the relationship between OSAS and all-cause and cardiovascular disease–related mortality, but it still largely unclear whether this association is causative or simply speculative and epidemiological. Basically, reliable clinical evidence supports the hypothesis that OSAS might be associated with essential and resistant hypertension, as well as with an incremental risk of developing stroke, cardiac rhythm perturbations (e.g., atrial fibrillation, bradyarrhythmias, supraventricular and ventricular arrhythmias), coronary artery disease, acute myocardial infarction, and heart failure. Although it is still unclear whether OSAS might represent an independent risk factor for several acute or chronic conditions, or rather might trigger cardiovascular disease in the presence of traditional cardiovascular risk factors (e.g., obesity, diabetes, and dyslipidemia), there is a plausible biological background underlying this association, in that most of the mechanisms implicated in the pathogenesis of OSAS (i.e., hypoxia, hypercapnia, negative intrathoracic pressure, micro-arousal, sympathetic hyperactivity, metabolic and hormonal changes, oxidative stress, phlogosis, endothelial dysfunction, hypercoagulability, and genetic predisposition) might also be involved in the pathogenesis of cardiovascular disorders. In this article we discuss the different aspects of the relationship between OSAS and pathogenically different conditions such as systemic hypertension, coronary artery disease, stroke, metabolic abnormalities, arrhythmias, and heart failure, and we also discuss the kaleidoscope of phenomena implicated in the pathogenesis of this challenging disease.
KEYWORDS
Sleep apnea - cardiovascular disease - hypertension - stroke - acute myocardial infarction
REFERENCES
- 1 Punjabi N M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5 (2) 136-143
- 2
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S.
The occurrence of sleep-disordered breathing among middle-aged adults.
N Engl J Med.
1993;
328
(17)
1230-1235
MissingFormLabel
- 3 Ancoli-Israel S, Kripke D F, Klauber M R, Mason W J, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep. 1991; 14 (6) 486-495
- 4 Newacheck P W, Taylor W R. Childhood chronic illness: prevalence, severity, and impact. Am J Public Health. 1992; 82 (3) 364-371
- 5 Guilleminault C, Lee J H, Chan A. Pediatric obstructive sleep apnea syndrome. Arch Pediatr Adolesc Med. 2005; 159 (8) 775-785
- 6 Grunstein R, Wilcox I, Yang T S, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord. 1993; 17 (9) 533-540
- 7 Wetter D W, Young T B, Bidwell T R, Badr M S, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994; 154 (19) 2219-2224
- 8 Mitler M M, Dawson A, Henriksen S J, Sobers M, Bloom F E. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res. 1988; 12 (6) 801-805
- 9 Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep. 1992; 15 (6, Suppl) S1-S4
- 10 Winkelman J W, Goldman H, Piscatelli N, Lukas S E, Dorsey C M, Cunningham S. Are thyroid function tests necessary in patients with suspected sleep apnea?. Sleep. 1996; 19 (10) 790-793
- 11 Grunstein R R, Ho K Y, Sullivan C E. Sleep apnea in acromegaly. Ann Intern Med. 1991; 115 (7) 527-532
- 12 Leiter J C, Knuth S L, Bartlett Jr D. The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis. 1985; 132 (6) 1242-1245
- 13 Liu P Y, Yee B, Wishart S M et al.. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab. 2003; 88 (8) 3605-3613
- 14 Redline S, Tishler P V. The genetics of sleep apnea. Sleep Med Rev. 2000; 4 (6) 583-602
- 15 Sundquist J, Li X, Friberg D, Hemminki K, Sundquist K. Obstructive sleep apnea syndrome in siblings: an 8-year Swedish follow-up study. Sleep. 2008; 31 (6) 817-823
- 16 Buxbaum S G, Elston R C, Tishler P V, Redline S. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis. Genet Epidemiol. 2002; 22 (3) 243-253
- 17 Gislason T, Johannsson J H, Haraldsson A et al.. Familial predisposition and cosegregation analysis of adult obstructive sleep apnea and the sudden infant death syndrome. Am J Respir Crit Care Med. 2002; 166 (6) 833-838
- 18 Friberg D, Sundquist J, Li X, Hemminki K, Sundquist K. Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy. Sleep. 2009; 32 (8) 1077-1083
- 19 Yaggi H K, Concato J, Kernan W N, Lichtman J H, Brass L M, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005; 353 (19) 2034-2041
- 20 Marshall N S, Wong K K, Liu P Y, Cullen S R, Knuiman M W, Grunstein R R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008; 31 (8) 1079-1085
- 21 McNicholas W T, Bonsigore M R, Bonsignore M R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007; 29 (1) 156-178
- 22 Somers V K, White D P, Amin R et al.. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008; 52 (8) 686-717
- 23 Kiely J L, McNicholas W T. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J. 2000; 16 (1) 128-133
- 24 Aytemir K, Deniz A, Yavuz B et al.. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med. 2007; 101 (6) 1277-1282
- 25 Ryan S, McNicholas W T. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem. 2008; 114 (4) 261-266
- 26 Ryan S, Taylor C T, McNicholas W T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax. 2009; 64 (7) 631-636
- 27 Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab. 2010; 95 (2) 483-495
- 28 Takagi T, Morser J, Gabazza E C et al.. The coagulation and protein C pathways in patients with sleep apnea. Lung. 2009; 187 (4) 209-213
- 29 Zamarrón C, Ricoy J, Riveiro A, Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung. 2008; 186 (3) 151-156
- 30 Mancia G. Autonomic modulation of the cardiovascular system during sleep. N Engl J Med. 1993; 328 (5) 347-349
- 31 Noda A, Yasuma F, Okada T, Yokota M. Influence of movement arousal on circadian rhythm of blood pressure in obstructive sleep apnea syndrome. J Hypertens. 2000; 18 (5) 539-544
- 32 Weiss J W, Remsburg S, Garpestad E, Ringler J, Sparrow D, Parker J A. Hemodynamic consequences of obstructive sleep apnea. Sleep. 1996; 19 (5) 388-397
- 33 Baguet J P, Barone-Rochette G, Pépin J L. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens. 2009; 23 (7) 431-443
- 34 Narkiewicz K, van de Borne P J, Pesek C A, Dyken M E, Montano N, Somers V K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 1999; 99 (9) 1183-1189
- 35 Gilmartin G S, Tamisier R, Curley M, Weiss J W. Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol. 2008; 295 (2) H778-H785
- 36 Greenberg H E, Sica A, Batson D, Scharf S M. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol. 1999; 86 (1) 298-305
- 37 Morgan B J, Denahan T, Ebert T J. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol. 1993; 74 (6) 2969-2975
- 38 Sukegawa M, Noda A, Yasuda Y et al.. Impact of microarousal associated with increased negative esophageal pressure in sleep-disordered breathing. Sleep Breath. 2009; 13 (4) 369-373
- 39 Stradling J R, Pitson D J, Bennett L, Barbour C, Davies R J. Variation in the arousal pattern after obstructive events in obstructive sleep apnea. Am J Respir Crit Care Med. 1999; 159 (1) 130-136
- 40 Davies R J, Belt P J, Roberts S J, Ali N J, Stradling J R. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol. 1993; 74 (3) 1123-1130
- 41 Brooks D, Horner R L, Kozar L F, Render-Teixeira C L, Phillipson E A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997; 99 (1) 106-109
- 42 Kimoff R J, Makino H, Horner R L et al.. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol. 1994; 76 (4) 1810-1817
- 43 Fletcher E C, Lesske J, Qian W, Miller III C C, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension. 1992; 19 (6 Pt 1) 555-561
- 44 Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A. Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet. 1984; 1 (8369) 126-131
- 45 Meanock C I. Influence of the vagus nerve on changes in heart rate during sleep apnoea in man. Clin Sci (Lond). 1982; 62 (2) 163-167
- 46 Hanly P J, George C F, Millar T W, Kryger M H. Heart rate response to breath-hold, Valsalva and Mueller maneuvers in obstructive sleep apnea. Chest. 1989; 95 (4) 735-739
- 47 Carlson J T, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin B G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993; 103 (6) 1763-1768
- 48 Somers V K, Dyken M E, Clary M P, Abboud F M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995; 96 (4) 1897-1904
- 49 Narkiewicz K, van de Borne P J, Cooley R L, Dyken M E, Somers V K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998; 98 (8) 772-776
- 50 Grassi G, Facchini A, Trevano F Q et al.. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005; 46 (2) 321-325
- 51 Peled N, Greenberg A, Pillar G, Zinder O, Levi N, Lavie P. Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens. 1998; 11 (11 Pt 1) 1284-1289
- 52 Dimsdale J E, Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler M G. Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest. 1997; 111 (3) 639-642
- 53 Jennum P, Wildschiødtz G, Christensen N J, Schwartz T. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. Am J Hypertens. 1989; 2 (11 Pt 1) 847-852
- 54 Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore M R. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest. 1993; 103 (3) 722-727
- 55 Narkiewicz K, van de Borne P J, Montano N, Dyken M E, Phillips B G, Somers V K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation. 1998; 97 (10) 943-945
- 56 Narkiewicz K, Pesek C A, Kato M, Phillips B G, Davison D E, Somers V K. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension. 1998; 32 (6) 1039-1043
- 57 Leuenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C, Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol. 1995; 79 (2) 581-588
- 58 Fletcher E C. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol. 2000; 119 (2-3) 189-197
- 59 Parati G, Di Rienzo M, Bonsignore M R et al.. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens. 1997; 15 (12 Pt 2) 1621-1626
- 60 Hedner J, Darpö B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 1995; 8 (2) 222-229
- 61 Veale D, Pépin J L, Wuyam B, Lévy P A. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure. Eur Respir J. 1996; 9 (10) 2122-2126
- 62 Narkiewicz K, Kato M, Phillips B G, Pesek C A, Davison D E, Somers V K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999; 100 (23) 2332-2335
- 63 Gjørup P H, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen E B. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens. 2007; 20 (1) 44-52
- 64 Phillips B G, Narkiewicz K, Pesek C A, Haynes W G, Dyken M E, Somers V K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999; 17 (1) 61-66
- 65 Møller D S, Lind P, Strunge B, Pedersen E B. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16 (4) 274-280
- 66 Pratt-Ubunama M N, Nishizaka M K, Boedefeld R L, Cofield S S, Harding S M, Calhoun D A. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007; 131 (2) 453-459
- 67 Calhoun D A, Nishizaka M K, Zaman M A, Harding S M. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004; 125 (1) 112-117
- 68 Takahashi S, Nakamura Y, Nishijima T, Sakurai S, Inoue H. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med. 2005; 99 (9) 1125-1131
- 69 Svatikova A, Olson L J, Wolk R et al.. Obstructive sleep apnea and aldosterone. Sleep. 2009; 32 (12) 1589-1592
- 70 Grassi G, Seravalle G, Quarti-Trevano F et al.. Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea. J Hypertens. 2010; 28 (6) 1313-1320
- 71 Steiropoulos P, Papanas N, Nena E et al.. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?. Sleep Med. 2009; 10 (8) 887-891
- 72 Lam D C, Xu A, Lam K S et al.. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J. 2009; 33 (2) 346-351
- 73 Cuhadaroğlu C, Utkusavaş A, Oztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009; 187 (2) 75-81
- 74 Lam J C, Xu A, Tam S et al.. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep. 2008; 31 (12) 1721-1727
- 75 Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi H K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009; 122 (12) 1122-1127
- 76 Ronksley P E, Hemmelgarn B R, Heitman S J et al.. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009; 64 (10) 834-839
- 77 Carneiro G, Togeiro S M, Ribeiro-Filho F F et al.. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord. 2009; 7 (6) 537-542
- 78 Dawson A, Abel S L, Loving R T et al.. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med. 2008; 4 (6) 538-542
- 79 Louis M, Punjabi N M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009; 106 (5) 1538-1544
- 80 Coughlin S R, Mawdsley L, Mugarza J A, Calverley P M, Wilding J P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004; 25 (9) 735-741
- 81 Li A M, Ng C, Ng S K et al.. Adipokines in children with obstructive sleep apnea and the effects of treatment. Chest. 2010; 137 (3) 529-535
- 82 Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med. 2008; 47 (21) 1843-1849
- 83 Drummond M, Winck J C, Guimarães J T, Santos A C, Almeida J, Marques J A. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med. 2008; 8 21
- 84 Trenell M I, Ward J A, Yee B J et al.. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab. 2007; 9 (5) 679-687
- 85 Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005; 127 (3) 716-721
- 86 Shimura R, Tatsumi K, Nakamura A et al.. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005; 127 (2) 543-549
- 87 Sanner B M, Kollhosser P, Buechner N, Zidek W, Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004; 23 (4) 601-604
- 88 Harsch I A, Konturek P C, Koebnick C et al.. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003; 22 (2) 251-257
- 89 Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold H K. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 2002; 122 (3) 829-839
- 90 Shimizu K, Chin K, Nakamura T et al.. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax. 2002; 57 (5) 429-434
- 91 Ip M S, Lam K S, Ho C, Tsang K W, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000; 118 (3) 580-586
- 92 Phillips B G, Kato M, Narkiewicz K, Choe I, Somers V K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000; 279 (1) H234-H237
- 93 Chin K, Shimizu K, Nakamura T et al.. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999; 100 (7) 706-712
- 94 Arnardottir E S, Mackiewicz M, Gislason T, Teff K L, Pack A I. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009; 32 (4) 447-470
- 95 Kheirandish L, Row B W, Li R C, Brittian K R, Gozal D. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep. 2005; 28 (11) 1412-1417
- 96 Prabhakar N R, Kumar G K, Nanduri J, Semenza G L. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal. 2007; 9 (9) 1397-1403
- 97 Row B W, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med. 2003; 167 (11) 1548-1553
- 98 Zhan G, Serrano F, Fenik P et al.. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med. 2005; 172 (7) 921-929
- 99 Montgomery-Downs H E, Krishna J, Roberts II L J, Gozal D. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath. 2006; 10 (4) 211-215
- 100 Barceló A, Barbé F, de la Peña M et al.. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J. 2006; 27 (4) 756-760
- 101 Carpagnano G E, Kharitonov S A, Resta O, Foschino-Barbaro M P, Gramiccioni E, Barnes P J. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003; 124 (4) 1386-1392
- 102 Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002; 165 (7) 934-939
- 103 Jordan W, Cohrs S, Degner D et al.. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm. 2006; 113 (2) 239-254
- 104 Schulz R, Mahmoudi S, Hattar K et al.. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000; 162 (2 Pt 1) 566-570
- 105 Yamauchi M, Nakano H, Maekawa J et al.. Oxidative stress in obstructive sleep apnea. Chest. 2005; 127 (5) 1674-1679
- 106 Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008; 134 (4) 686-692
- 107 de Lima A M, Franco C M, de Castro C M, Bezerra A D, Atade L, Halpern A. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration. 2009; July 3; (Epub ahead of print)
- 108 Gozal D, Serpero L D, Sans Capdevila O, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med. 2008; 9 (3) 254-259
- 109 Punjabi N M, Beamer B A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep. 2007; 30 (1) 29-34
- 110 Tauman R, O'Brien L M, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath. 2007; 11 (2) 77-84
- 111 Ursavaş A, Karadağ M, Rodoplu E, Yilmaztepe A, Oral H B, Gözü R O. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration. 2007; 74 (5) 525-532
- 112 Kobayashi K, Nishimura Y, Shimada T et al.. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest. 2006; 129 (3) 632-637
- 113 Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci. 2005; 1051 340-350
- 114 Minoguchi K, Tazaki T, Yokoe T et al.. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest. 2004; 126 (5) 1473-1479
- 115 Ciftci T U, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004; 28 (2) 87-91
- 116 Teramoto S, Yamamoto H, Ouchi Y. Increased plasma interleukin-6 is associated with the pathogenesis of obstructive sleep apnea syndrome. Chest. 2004; 125 (5) 1964-1965 author reply 1965
- 117 Thomopoulos C, Tsioufis C, Dimitriadis K et al.. Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens. 2009; 23 (1) 65-67
- 118 Arias M A, García-Río F, Alonso-Fernández A et al.. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J. 2008; 32 (4) 1009-1015
- 119 Sahlman J, Miettinen K, Peuhkurinen K Kuopio Sleep Apnoea Group et al. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res. 2010; 19 (2) 341-348
- 120 Tamaki S, Yamauchi M, Fukuoka A et al.. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med. 2009; 48 (15) 1255-1262
- 121 Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002; 165 (1) 67-70
- 122 Imagawa S, Yamaguchi Y, Higuchi M et al.. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea—hypopnea syndrome. Blood. 2001; 98 (4) 1255-1257
- 123 Teramoto S, Kume H, Yamamoto H et al.. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med. 2003; 42 (8) 681-685
- 124 Kähler C M, Wechselberger J, Molnar C, Prior C. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia. Am J Respir Crit Care Med. 2003; 167 (1) 92-93 author reply 93
- 125 Gozal D, Lipton A J, Jones K L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep. 2002; 25 (1) 59-65
- 126 Gunsilius E, Petzer A L, Gastl G A. Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome. Blood. 2002; 99 (1) 393-394
- 127 Kohler M, Ayers L, Pepperell J C et al.. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax. 2009; 64 (1) 67-73
- 128 Vgontzas A N, Zoumakis E, Bixler E O et al.. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008; 38 (8) 585-595
- 129 Vgontzas A N, Zoumakis E, Lin H M, Bixler E O, Trakada G, Chrousos G P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab. 2004; 89 (9) 4409-4413
- 130 Barceló A, de la Peña M, Ayllón O et al.. Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea. Respiration. 2009; 77 (1) 85-90
- 131 Akinnusi M E, Paasch L L, Szarpa K R, Wallace P K, El Solh A A. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration. 2009; 77 (1) 25-31
- 132 Cox D, Bradford A. Continuous positive airway pressure and platelet activation in obstructive sleep apnoea. Respiration. 2009; 77 (1) 18-20
- 133 Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. Chest. 2001; 119 (4) 1085-1091
- 134 Kato M, Roberts-Thomson P, Phillips B G et al.. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000; 102 (21) 2607-2610
- 135 Oflaz H, Cuhadaroglu C, Pamukcu B et al.. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration. 2006; 73 (6) 751-756
- 136 Tanriverdi H, Evrengul H, Kara C O et al.. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration. 2006; 73 (6) 741-750
- 137 Gozal D, Kheirandish-Gozal L, Serpero L D, Sans Capdevila O, Dayyat E. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation. 2007; 116 (20) 2307-2314
- 138 Chung S, Yoon I Y, Shin Y K et al.. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep. 2007; 30 (8) 997-1001
- 139 Carlson J T, Rångemark C, Hedner J A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens. 1996; 14 (5) 577-584
- 140 Duchna H W, Orth M, Schultze-Werninghaus G, Guilleminault C, Stoohs R A. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath. 2005; 9 (3) 97-103
- 141 Cross M D, Mills N L, Al-Abri M et al.. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax. 2008; 63 (7) 578-583
- 142 Ohike Y, Kozaki K, Iijima K et al.. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure—possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J. 2005; 69 (2) 221-226
- 143 Lattimore J L, Wilcox I, Skilton M, Langenfeld M, Celermajer D S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax. 2006; 61 (6) 491-495
- 144 Comondore V R, Cheema R, Fox J et al.. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung. 2009; 187 (1) 17-22
- 145 Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest. 2007; 131 (3) 740-749
- 146 Duchna H W, Orth M, Schultze-Werninghaus G, Guilleminault C, Stoohs R A. Antihypertensive treatment and endothelium-dependent venodilation in sleep-disordered breathing. Sleep Breath. 2006; 10 (3) 115-122
- 147 Grebe M, Eisele H J, Weissmann N et al.. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med. 2006; 173 (8) 897-901
- 148 El Solh A A, Saliba R, Bosinski T, Grant B J, Berbary E, Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J. 2006; 27 (5) 997-1002
- 149 Zhong X, Xiao Y, Basner R C. Effects of antihypertensives on arterial responses associated with obstructive sleep apneas. Chin Med J (Engl). 2005; 118 (2) 123-129
- 150 Protogerou A D, Laaban J P, Czernichow S et al.. Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. J Hum Hypertens. 2008; 22 (6) 415-422
- 151 Kohler M, Craig S, Nicoll D, Leeson P, Davies R J, Stradling J R. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med. 2008; 178 (9) 984-988
- 152 Drager L F, Diegues-Silva L, Diniz P M et al.. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens. 2010; 23 (3) 249-254
- 153 Suzuki T, Nakano H, Maekawa J et al.. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep. 2004; 27 (1) 129-133
- 154 Baguet J P, Hammer L, Lévy P et al.. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest. 2005; 128 (5) 3407-3412
- 155 Minoguchi K, Yokoe T, Tazaki T et al.. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med. 2005; 172 (5) 625-630
- 156 Drager L F, Bortolotto L A, Krieger E M, Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension. 2009; 53 (1) 64-69
- 157 Lavie L, Perelman A, Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest. 2001; 120 (3) 900-908
- 158 Ozkan Y, Firat H, Simşek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath. 2008; 12 (2) 149-154
- 159 Takagi T, Morser J, Gabazza E C et al.. The coagulation and protein C pathways in patients with sleep apnea. Lung. 2009; 187 (4) 209-213
- 160 von Känel R, Le D T, Nelesen R A, Mills P J, Ancoli-Israel S, Dimsdale J E. The hypercoagulable state in sleep apnea is related to comorbid hypertension. J Hypertens. 2001; 19 (8) 1445-1451
- 161 von Känel R, Loredo J S, Ancoli-Israel S, Dimsdale J E. Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure. Sleep Breath. 2006; 10 (3) 139-146
- 162 von Känel R, Loredo J S, Powell F L, Adler K A, Dimsdale J E. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc. 2005; 33 (4) 369-377
- 163 Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer B E. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology. 2005; 104 (2) 92-96
- 164 Ishikawa J, Hoshide S, Eguchi K et al.. Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. J Hypertens. 2008; 26 (6) 1181-1187
- 165 Zamarrón C, Ricoy J, Riveiro A, Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung. 2008; 186 (3) 151-156
- 166 Riha R L. Genetic aspects of the obstructive sleep apnoea/hypopnoea syndrome—is there a common link with obesity?. Respiration. 2009; 78 (1) 5-17
- 167
Doi M, Takahashi Y, Komatsu R et al..
Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated
adrenal Hsd3b6.
Nat Med.
2010;
16
(1)
67-74
MissingFormLabel
- 168 Portaluppi F, Provini F, Cortelli P et al.. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens. 1997; 15 (11) 1227-1233
- 169 Stoohs R A, Gingold J, Cohrs S, Harter R, Finlayson E, Guilleminault C. Sleep-disordered breathing and systemic hypertension in the older male. J Am Geriatr Soc. 1996; 44 (11) 1295-1300
- 170 Fletcher E C, DeBehnke R D, Lovoi M S, Gorin A B. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med. 1985; 103 (2) 190-195
- 171 Logan A G, Perlikowski S M, Mente A et al.. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001; 19 (12) 2271-2277
- 172 Gonçalves S C, Martinez D, Gus M et al.. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007; 132 (6) 1858-1862
- 173 Chobanian A V, Bakris G L, Black H R Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42 (6) 1206-1252
- 174 Tishler P V, Larkin E K, Schluchter M D, Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA. 2003; 289 (17) 2230-2237
- 175 Newman A B, Foster G, Givelber R, Nieto F J, Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med. 2005; 165 (20) 2408-2413
- 176 Nieto F J, Young T B, Lind B K et al.. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000; 283 (14) 1829-1836
- 177 O'Connor G T, Caffo B, Newman A B et al.. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009; 179 (12) 1159-1164
- 178
Peppard P E, Young T, Palta M, Skatrud J.
Prospective study of the association between sleep-disordered breathing and hypertension.
N Engl J Med.
2000;
342
(19)
1378-1384
MissingFormLabel
- 179 Bixler E O, Vgontzas A N, Lin H M et al.. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000; 160 (15) 2289-2295
- 180 Haas D C, Foster G L, Nieto F J et al.. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005; 111 (5) 614-621
- 181 Bixler E O, Vgontzas A N, Lin H M et al.. Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension. 2008; 52 (5) 841-846
- 182 Davies C W, Crosby J H, Mullins R L, Barbour C, Davies R J, Stradling J R. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax. 2000; 55 (9) 736-740
- 183 Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep. 1996; 19 (5) 382-387
- 184 Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl. 1994; 12 (5) S13-S21
- 185 Ancoli-Israel S, Stepnowsky C, Dimsdale J, Marler M, Cohen-Zion M, Johnson S. The effect of race and sleep-disordered breathing on nocturnal BP “dipping”: analysis in an older population. Chest. 2002; 122 (4) 1148-1155
- 186 Noda A, Okada T, Hayashi H, Yasuma F, Yokota M. 24-hour ambulatory blood pressure variability in obstructive sleep apnea syndrome. Chest. 1993; 103 (5) 1343-1347
- 187 Baguet J-P, Lévy P, Barone-Rochette G et al.. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens. 2008; 26 (5) 885-892
- 188 Narkiewicz K, Montano N, Cogliati C, van de Borne P J, Dyken M E, Somers V K. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998; 98 (11) 1071-1077
- 189 Baguet J-P, Hammer L, Lévy P et al.. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005; 23 (3) 521-527
- 190 Barbé F, Mayoralas L R, Duran J et al.. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001; 134 (11) 1015-1023
- 191 Barnes M, Houston D, Worsnop C J et al.. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2002; 165 (6) 773-780
- 192 Becker H F, Jerrentrup A, Ploch T et al.. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003; 107 (1) 68-73
- 193 Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al.. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006; 129 (6) 1459-1467
- 194 Coughlin S R, Mawdsley L, Mugarza J A, Wilding J P, Calverley P M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007; 29 (4) 720-727
- 195 Dimsdale J E, Loredo J S, Profant J. Effect of continuous positive airway pressure on blood pressure : a placebo trial. Hypertension. 2000; 35 (1 Pt 1) 144-147
- 196 Faccenda J F, Mackay T W, Boon N A, Douglas N J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001; 163 (2) 344-348
- 197 Norman D, Loredo J S, Nelesen R A et al.. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension. 2006; 47 (5) 840-845
- 198 Pepperell J C, Ramdassingh-Dow S, Crosthwaite N et al.. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002; 359 (9302) 204-210
- 199 Robinson G V, Smith D M, Langford B A, Davies R J, Stradling J R. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J. 2006; 27 (6) 1229-1235
- 200 Usui K, Bradley T D, Spaak J et al.. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol. 2005; 45 (12) 2008-2011
- 201 Arias M A, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation. 2005; 112 (3) 375-383
- 202 Barnes M, McEvoy R D, Banks S et al.. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004; 170 (6) 656-664
- 203 Engleman H M, Gough K, Martin S E, Kingshott R N, Padfield P L, Douglas N J. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep. 1996; 19 (5) 378-381
- 204 Ip M S, Tse H F, Lam B, Tsang K W, Lam W K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004; 169 (3) 348-353
- 205 Kaneko Y, Floras J S, Usui K et al.. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003; 348 (13) 1233-1241
- 206 Mansfield D R, Gollogly N C, Kaye D M, Richardson M, Bergin P, Naughton M T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004; 169 (3) 361-366
- 207 Mills P J, Kennedy B P, Loredo J S, Dimsdale J E, Ziegler M G. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol. 2006; 100 (1) 343-348
- 208 Alajmi M, Mulgrew A T, Fox J et al.. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007; 185 (2) 67-72
- 209 Haentjens P, Van Meerhaeghe A, Moscariello A et al.. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007; 167 (8) 757-764
- 210 Bazzano L A, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007; 50 (2) 417-423
- 211 Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea. Sleep. 1999; 22 (7) 849-853
- 212 Hermida R C, Zamarrón C, Ayala D E, Calvo C. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit. 2004; 9 (4) 193-202
- 213 Gotsopoulos H, Kelly J J, Cistulli P A. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep. 2004; 27 (5) 934-941
- 214 Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2000; 161 (5) 1423-1428
- 215 Wustmann K, Kucera J P, Scheffers I et al.. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009; 54 (3) 530-536
- 216 Arzt M, Young T, Finn L, Skatrud J B, Bradley T D. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005; 172 1447-1451
- 217 Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. 2006; 60 (1) 69-73
- 218 Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil. 1995; 76 (1) 71-76
- 219 Dyken M E, Somers V K, Yamada T, Ren Z Y, Zimmerman M B. Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996; 27 (3) 401-407
- 220 Shahar E, Whitney C W, Redline S et al.. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163 (1) 19-25
- 221 Good D C, Henkle J Q, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke. 1996; 27 (2) 252-259
- 222 Sahlin C, Sandberg O, Gustafson Y et al.. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008; 168 (3) 297-301
- 223 Palomäki H. Snoring and the risk of ischemic brain infarction. Stroke. 1991; 22 (8) 1021-1025
- 224 Neau J-Ph, Meurice J C, Paquereau J, Chavagnat J J, Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand. 1995; 92 (1) 63-68
- 225 Askenasy J JM, Goldhammer I. Sleep apnea as a feature of bulbar stroke. Stroke. 1988; 19 (5) 637-639
- 226 Bogousslavsky J, Khurana R, Deruaz J P et al.. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol. 1990; 28 (5) 668-673
- 227 Droste D W, Lüdemann P, Anders F et al.. Middle cerebral artery blood flow velocity, end-tidal pCO2 and blood pressure in patients with obstructive sleep apnea and in healthy subjects during continuous positive airway pressure breathing. Neurol Res. 1999; 21 (8) 737-741
- 228 Diomedi M, Placidi F, Cupini L M, Bernardi G, Silvestrini M. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology. 1998; 51 (4) 1051-1056
- 229 Hajak G, Klingelhöfer J, Schulz-Varszegi M, Sander D, Rüther E. Sleep apnea syndrome and cerebral hemodynamics. Chest. 1996; 110 (3) 670-679
- 230 Dikmenoğlu N, Ciftçi B, Ileri E et al.. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med. 2006; 7 (3) 255-261
- 231 Furtner M, Staudacher M, Frauscher B et al.. Cerebral vasoreactivity decreases overnight in severe obstructive sleep apnea syndrome: a study of cerebral hemodynamics. Sleep Med. 2009; 10 (8) 875-881
- 232 Altin R, Ozdemir H, Mahmutyazicioğlu K et al.. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J Clin Ultrasound. 2005; 33 (2) 80-86
- 233 Beelke M, Angeli S, Del Sette M et al.. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med. 2003; 4 (3) 219-223
- 234 Wessendorf T E, Thilmann A F, Wang Y M, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 2000; 162 (6) 2039-2042
- 235 Geiser T, Buck F, Meyer B J, Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration. 2002; 69 (3) 229-234
- 236 Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest. 1995; 108 (3) 625-630
- 237 Hedner J, Carlson J, Rangemark C, Gleerup G, Wither K. Platelet function and fibrinolytic activity in patients with sleep apnoea. J Sleep Res. 1994; 3 (Suppl 1) 101
- 238 Sandberg O, Franklin K A, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J. 2001; 18 (4) 630-634
- 239 Hsu C Y, Vennelle M, Li H Y, Engleman H M, Dennis M S, Douglas N J. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry. 2006; 77 (10) 1143-1149
- 240 Shaw J E, Punjabi N M, Wilding J P, Alberti K G, Zimmet P Z. International Diabetes Federation Taskforce on Epidemiology and Prevention . Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008; 81 (1) 2-12
- 241 Keckeis M, Lattova Z, Maurovich-Horvat E et al.. Impaired glucose tolerance in sleep disorders. PLoS ONE. 2010; 5 (3) e9444
- 242 Punjabi N M, Shahar E, Redline S, Gottlieb D J, Givelber R, Resnick H E. Sleep Heart Health Study Investigators . Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004; 160 (6) 521-530
- 243 Punjabi N M, Beamer B A. Alterations in Glucose Disposal in Sleep-disordered Breathing. Am J Respir Crit Care Med. 2009; 179 (3) 235-240
- 244 Aronsohn R S, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010; 181 (5) 507-513
- 245 Otake K, Sasanabe R, Hasegawa R et al.. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med. 2009; 48 (21) 1863-1868
- 246 Mahmood K, Akhter N, Eldeirawi K et al.. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med. 2009; 5 (3) 215-221
- 247 Meslier N, Gagnadoux F, Giraud P et al.. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J. 2003; 22 (1) 156-160
- 248 Levinson P D, McGarvey S T, Carlisle C C, Eveloff S E, Herbert P N, Millman R P. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 1993; 103 (5) 1336-1342
- 249 Grunstein R R, Stenlöf K, Hedner J, Sjöström L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord. 1995; 19 (6) 410-418
- 250 Reichmuth K J, Austin D, Skatrud J B, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005; 172 (12) 1590-1595
- 251 Polotsky V Y, Li J, Punjabi N M et al.. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol. 2003; 552 (Pt 1) 253-264
- 252 Tasali E, Leproult R, Ehrmann D A, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008; 105 (3) 1044-1049
- 253 Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005; 99 (5) 2008-2019
- 254 Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2003; 70 (6) 665-671
- 255 West S D, Nicoll D J, Wallace T M, Matthews D R, Stradling J R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007; 62 (11) 969-974
- 256 Babu A R, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005; 165 (4) 447-452
- 257 Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008; 81 (1) e8-e11
- 258 Yee B, Liu P, Phillips C, Grunstein R. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med. 2004; 10 (6) 475-481
- 259 Luboshitzky R, Aviv A, Hefetz A et al.. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab. 2002; 87 (7) 3394-3398
- 260 Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest. 2003; 26 (6) 493-498
- 261 Netzer N C, Eliasson A H, Strohl K P. Women with sleep apnea have lower levels of sex hormones. Sleep Breath. 2003; 7 (1) 25-29
- 262 Lanfranco F, Gianotti L, Pivetti S et al.. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf). 2004; 60 (1) 41-48
- 263 Punjabi N M, Polotsky V Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005; 99 (5) 1998-2007
- 264 Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006; 28 (3) 596-602
- 265 Franklin K A, Nilsson J B, Sahlin C, Näslund U. Sleep apnoea and nocturnal angina. Lancet. 1995; 345 (8957) 1085-1087
- 266 Hung J, Whitford E G, Parsons R W, Hillman D R. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990; 336 (8710) 261-264
- 267 Schäfer H, Koehler U, Ewig S, Hasper E, Tasci S, Lüderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology. 1999; 92 (2) 79-84
- 268 Mooe T, Rabben T, Wiklund U, Franklin K A, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996; 109 (3) 659-663
- 269 Aboyans V, Cassat C, Lacroix P et al.. Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study. Cardiology. 2000; 94 (3) 188-192
- 270 Sorajja D, Gami A S, Somers V K, Behrenbeck T R, Garcia-Touchard A, Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest. 2008; 133 (4) 927-933
- 271 Lee C H, Khoo S M, Tai B C et al.. Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest. 2009; 135 (6) 1488-1495
- 272 Peker Y, Hedner J, Kraiczi H, Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med. 2000; 162 (1) 81-86
- 273 Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007; 99 (1) 26-30
- 274 Steiner S, Schueller P O, Hennersdorf M G, Behrendt D, Strauer B E. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res. 2008; 9 50
- 275 Nakashima H, Katayama T, Takagi C et al.. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J. 2006; 27 (19) 2317-2322
- 276 Turmel J, Sériès F, Boulet L P et al.. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol. 2009; 132 (2) 203-209
- 277 Gami A S, Rader S, Svatikova A et al.. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest. 2007; 131 (1) 118-121
- 278 Belaidi E, Joyeux-Faure M, Ribuot C, Launois S H, Levy P, Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol. 2009; 53 (15) 1309-1317
- 279 Kuniyoshi F H, Garcia-Touchard A, Gami A S et al.. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008; 52 (5) 343-346
- 280 Cassar A, Morgenthaler T I, Lennon R J, Rihal C S, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50 (14) 1310-1314
- 281 Milleron O, Pillière R, Foucher A et al.. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004; 25 (9) 728-734
- 282 Doherty L S, Kiely J L, Swan V, McNicholas W T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest. 2005; 127 (6) 2076-2084
- 283 Peled N, Abinader E G, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol. 1999; 34 (6) 1744-1749
- 284 Harbison J, O'Reilly P, McNicholas W T. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest. 2000; 118 (3) 591-595
- 285 Gami A S, Somers V K. Implications of obstructive sleep apnea for atrial fibrillation and sudden cardiac death. J Cardiovasc Electrophysiol. 2008; 19 (9) 997-1003
- 286 Roche F, Gaspoz J M, Court-Fortune I et al.. Alteration of QT rate dependence reflects cardiac autonomic imbalance in patients with obstructive sleep apnea syndrome. Pacing Clin Electrophysiol. 2003; 26 (7 Pt 1) 1446-1453
- 287 Szymanowska K, Piatkowska A, Nowicka A, Cofta S, Wierzchowiecki M. Heart rate turbulence in patients with obstructive sleep apnea syndrome. Cardiol J. 2008; 15 (5) 441-445
- 288 Gillis A M, Stoohs R, Guilleminault C. Changes in the QT interval during obstructive sleep apnea. Sleep. 1991; 14 (4) 346-350
- 289 Ito R, Hamada H, Yokoyama A et al.. Successful treatment of obstructive sleep apnea syndrome improves autonomic nervous system dysfunction. Clin Exp Hypertens. 2005; 27 (2-3) 259-267
- 290 Nakamura T, Chin K, Hosokawa R et al.. Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2004; 125 (6) 2107-2114
- 291 Roche F, Barthélémy J C, Garet M, Duverney D, Pichot V, Sforza E. Continuous positive airway pressure treatment improves the QT rate dependence adaptation of obstructive sleep apnea patients. Pacing Clin Electrophysiol. 2005; 28 (8) 819-825
- 292 Aytemir K, Deniz A, Yavuz B et al.. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med. 2007; 101 (6) 1277-1282
- 293 Guilleminault C, Connolly S J, Winkle R A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52 (5) 490-494
- 294 Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest. 1994; 106 (2) 466-471
- 295 Mehra R, Benjamin E J, Shahar E Sleep Heart Health Study et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006; 173 (8) 910-916
- 296 Fuster V, Rydén L E, Cannom D S American College of Cardiology/American Heart Association Task Force on Practice Guidelines et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114 (7) e257-e354
- 297 Chen P S, Douglas P. Douglas P. Zipes Lecture. Neural mechanisms of atrial fibrillation. Heart Rhythm. 2006; 3 (11) 1373-1377
- 298 Asirvatham S J, Kapa S. Sleep apnea and atrial fibrillation: the autonomic link. J Am Coll Cardiol. 2009; 54 (22) 2084-2086
- 299 Kanagala R, Murali N S, Friedman P A et al.. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003; 107 (20) 2589-2594
- 300 Abe H, Takahashi M, Yaegashi H et al.. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels. 2010; 25 (1) 63-69
- 301 Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest. 1982; 69 (6) 1286-1292
- 302 Ji K H, Kim D H, Yun C H. Severe obstructive sleep apnea syndrome with symptomatic daytime bradyarrhythmia. J Clin Sleep Med. 2009; 5 (3) 246-247
- 303 Grimm W, Koehler U, Fus E et al.. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol. 2000; 86 (6) 688-692, A9
- 304 Javaheri S, Parker T J, Liming J D et al.. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998; 97 (21) 2154-2159
- 305 Sin D D, Fitzgerald F, Parker J D, Newton G, Floras J S, Bradley T D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999; 160 (4) 1101-1106
- 306 Wang H, Parker J D, Newton G E et al.. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007; 49 (15) 1625-1631
- 307 Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990; 8 (10) 941-946
- 308 Laaban J P, Pascal-Sebaoun S, Bloch E, Orvoën-Frija E, Oppert J M, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest. 2002; 122 (4) 1133-1138
- 309 Tkacova R, Rankin F, Fitzgerald F S, Floras J S, Bradley T D. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998; 98 (21) 2269-2275
- 310 Chen L, Shi Q, Scharf S M. Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol. 2000; 88 (3) 1051-1060
Cristiano FavaM.D. Ph.D.
Department of Medicine, Division of Internal Medicine C
Piazza LA Scuro 10, 37134 Verona, Italy
eMail: cristiano.fava@med.lu.se